Nuage Vision was created to energize innovation management & commercialisation in companies and universities with a primary focus on life sciences and biotechnology

 

Invention – Innovation – Commercialisation


Nuage Vision’s founder, Dr Pete Hotten has extensive experience in this process. It involves both internal and external interactions. From identifying what IP you have or need, to matching that IP to unmet market needs and then taking product to market. Nuage Vision offers consultancy and mentoring to help you achieve your objectives.

"Pete’s current board positions include non-executive roles on a biotech developing cancer therapeutics and a medical device company developing non-invasive technology for sampling lungs."

Dr Pete Hotten

Pete has over 25 years’ experience in shaping research outputs, across many life-science related disciplines, to optimise the probability of commercial success. In doing so, Pete has helped launch many companies and licensed a range of technologies from major research organisations (e.g., Oxford). As director of Licensing & Business Development at Oxford Gene Technology for 10 years Pete experienced the range of activities involved in creating and scaling a biotech company.

Initially trained in chemistry and microbiology Pete retains a particular interest in the life sciences but has applied his skills to companies operating in a diverse set of sectors. Including technologies addressing; language learning, insect borne disease control, enhanced pollination techniques, new animation software, bone repair, and sonar technology

Specialist in mentoring management teams and with skills in, for example, IP strategy and negotiations concerning aspects such as investment and licensing agreements, Pete is happy to be involved to the extent required including taking on non-executive Board positions.

Pete is currently a founder director of both Nuage Vision Ltd and CommLIT.Online Ltd (providers of educational material re the skills and disciplines required to run companies), director of PulmoBioMed Ltd (a medical device company), a director of Virothera Ltd (molecular biology – vaccines/therapeutics), director of Awen Oncology (cancer therapeutics) and a member of the Royal Society Industrial College.

" I have known Pete Hotten for many years and have seen him in many roles, but how I think of him as the master at getting the best out of intellectual property. Whether it is in the form of developing an IP strategy or in negotiating a favourable deal through the licensing of that technology"

Bruce Savage
GFC Diagnostics Ltd

“Pete helped raise the awareness of IP in the organisation and provided valuable input around integrating IP processes, thinking and management systems; the business continues to build upon these foundational elements as we strengthen our commercial and technical capabilities”

Robert Sherville-Payne
General Counsel, Medicines Discovery Catapult

“It was a pleasure to work with Pete who provided sound advice, particularly on IP matters such as freedom-to-operate and competitor analysis in the early stages of 4D BioMaterials”

Philip Smith
CEO, 4D Biomaterials